Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Induced coma
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Theory == Barbiturates reduce the metabolic rate of brain tissue, as well as the [[cerebral blood flow]]. With these reductions, the [[blood vessel]]s in the brain narrow, resulting in a shrunken brain, and hence lower [[intracranial pressure]]. The hope is that, with the swelling relieved, the pressure decreases and some or all [[brain damage]] may be averted. Several studies have supported this theory by showing reduced mortality when treating refractory intracranial hypertension with a barbiturate coma.<ref>{{cite journal | vauthors = | title = The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Use of barbiturates in the control of intracranial hypertension | journal = Journal of Neurotrauma | volume = 17 | issue = 6–7 | pages = 527–530 | year = 2000 | pmid = 10937896 | doi = 10.1089/neu.2000.17.527 | publisher = Mary Ann Liebert, Inc. }}</ref><ref>{{cite journal | vauthors = Lee MW, Deppe SA, Sipperly ME, Barrette RR, Thompson DR | title = The efficacy of barbiturate coma in the management of uncontrolled intracranial hypertension following neurosurgical trauma | journal = Journal of Neurotrauma | volume = 11 | issue = 3 | pages = 325–331 | date = June 1994 | pmid = 7996586 | doi = 10.1089/neu.1994.11.325 }}</ref><ref>{{cite journal | vauthors = Nordby HK, Nesbakken R | title = The effect of high dose barbiturate decompression after severe head injury. A controlled clinical trial | journal = Acta Neurochirurgica | volume = 72 | issue = 3–4 | pages = 157–166 | year = 1984 | pmid = 6382945 | doi = 10.1007/BF01406868 | s2cid = 12215655 }}</ref> About 60% of the glucose and oxygen used by the brain is meant for its electrical activity and the rest for all other activities such as metabolism.<ref>{{cite web | title= Update on Techniques for Neuroprotection during Hypothermic Arrest | publisher= Society of Cardiovascular Anesthesiologists | author= Grocott HP | url= http://www.scahq.org/files/Conference_2014_Annual_Syllabi_Sessions/SCA_2014_syllabus_Grocott_Update_on_techniques_for_neuroprotection_during_hypothermic_arrest.pdf | access-date= 14 April 2016 | quote= approximately 60% of CMRO2 is utilized for neuronal function (with the remainder being required for cellular integrity) | archive-url= https://web.archive.org/web/20160423192027/http://www.scahq.org/files/Conference_2014_Annual_Syllabi_Sessions/SCA_2014_syllabus_Grocott_Update_on_techniques_for_neuroprotection_during_hypothermic_arrest.pdf | archive-date= 23 April 2016 | url-status= dead }}</ref> When barbiturates are given to brain injured patients for induced coma, they act by reducing the electrical activity of the brain, which reduces the metabolic and oxygen demand.<ref>{{cite web| title =Cerebral protection and resuscitation| publisher =CNS Clinic – Jordan – Amman| url =http://www.neuroanesthesia.info/cerebralprotection.htm| access-date =16 April 2016| quote =The primary mechanism of protection involves a reduction in CMRo2 of up to 55% to 60% at which point the EEG becomes isoelectric.| archive-date =4 November 2020| archive-url =https://web.archive.org/web/20201104172132/http://www.neuroanesthesia.info/cerebralprotection.htm| url-status =dead}}</ref> Their action limits oxidative damage to lipid membranes and may scavenge free radicals. They also lead to reduced vasogenic edema, fatty acid release and intracellular calcium release.<ref name=Mariano2014/> The infusion dose rate of barbiturates is increased under monitoring by [[electroencephalography]] until burst suppression or cortical electrical silence (isoelectric "flatline") is attained.<ref>{{cite web| title =Barbiturate Coma| publisher =Trauma.org| url =http://www.trauma.org/archive/anaesthesia/barbcoma.html| access-date =16 April 2016| quote =Therapeutic EEG response: burst suppression or cortical electrical silence (with preservation of SSEP and BAEF).| archive-url =https://web.archive.org/web/20160819000601/http://www.trauma.org/archive/anaesthesia/barbcoma.html| archive-date =19 August 2016| url-status =dead}}</ref> Once there is improvement in the patient's general condition, the barbiturates are withdrawn gradually and the patient regains consciousness. Controversy exists over the benefits of using barbiturates to control [[intracranial hypertension]]. Some studies have found that barbiturate-induced coma can reduce intracranial hypertension but does not necessarily prevent brain damage.<ref name=Mariano2014/> Furthermore, the reduction in intracranial hypertension may not be sustained. Some [[Randomized controlled trial|randomized trial]]s have failed to demonstrate any survival or morbidity benefit of induced coma in diverse conditions such as neurosurgical operations, [[head trauma]],<ref>{{cite journal | vauthors = Schwartz ML, Tator CH, Rowed DW, Reid SR, Meguro K, Andrews DF | title = The University of Toronto head injury treatment study: a prospective, randomized comparison of pentobarbital and mannitol | journal = The Canadian Journal of Neurological Sciences. Le Journal Canadien des Sciences Neurologiques | volume = 11 | issue = 4 | pages = 434–440 | date = November 1984 | pmid = 6440704 | doi = 10.1017/s0317167100045960 | doi-access = free }}</ref> [[cerebral aneurysm|intracranial aneurysm]] rupture, [[intracranial hemorrhage]], ischemic [[stroke]], and [[status epilepticus]]. If the patient survives, cognitive impairment may also follow recovery from the coma.<ref>{{cite journal | vauthors = Schalén W, Sonesson B, Messeter K, Nordström G, Nordström CH | title = Clinical outcome and cognitive impairment in patients with severe head injuries treated with barbiturate coma | journal = Acta Neurochirurgica | volume = 117 | issue = 3–4 | pages = 153–159 | year = 1992 | pmid = 1414516 | doi = 10.1007/BF01400613 | s2cid = 23032307 }}</ref> Due to these risks, barbiturate-induced coma should be reserved for cases of refractory intracranial pressure elevation.<ref name=Mariano2014>{{cite book | vauthors = Mariano GL, Fink ME, Hoffman C, Rosengart A | date = 2014 | chapter = Intracranial pressure: monitoring and management. | veditors = Hall JB, Schmidt GA, Kress JP | title = Principles of Critical Care | edition = 4th | publisher = McGraw Hill | chapter-url = https://accessmedicine.mhmedical.com/content.aspx?bookid=1340§ionid=80036194 | isbn = 978-0-07-173881-1 }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)